tebrofen has been researched along with 2,4,6-triiodoresorcinol in 1 studies
| Studies (tebrofen) | Trials (tebrofen) | Recent Studies (post-2010) (tebrofen) | Studies (2,4,6-triiodoresorcinol) | Trials (2,4,6-triiodoresorcinol) | Recent Studies (post-2010) (2,4,6-triiodoresorcinol) |
|---|---|---|---|---|---|
| 6 | 1 | 1 | 5 | 1 | 0 |
| Protein | Taxonomy | tebrofen (IC50) | 2,4,6-triiodoresorcinol (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.33 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadeeva, NI; Gerasina, SF | 1 |
1 trial(s) available for tebrofen and 2,4,6-triiodoresorcinol
| Article | Year |
|---|---|
[Problems of the molecular mechanism of the effects of synthetic antiviral drugs].
Topics: Antiviral Agents; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Drug Evaluation, Preclinical; Fluorenes; Humans; In Vitro Techniques; Influenza A virus; Influenza, Human; Naphthoquinones; Polybrominated Biphenyls; Resorcinols; RNA, Viral; Viral Proteins | 1989 |